Superseded · version 1: BPC-157^↗

Related names recorded in this version: Body protection compound 157^↗

A research peptide with FDA compounding records and a recent trial-registry entry.^↗↗

This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.

What this version reported

FDA's 2026 briefing says BPC-157 is not a component of an FDA-approved drug and describes limited safety information and characterization concerns. ClinicalTrials.gov also lists a recruiting study; registration is not proof of effectiveness.^↗↗

Organizations named in cited records:

U.S. Food and Drug Administration^↗
Hudson Biotech^↗

Trial records: NCT07437547

Sources for this version

1
FDA briefing document for BPC-157-related bulk drug substances ↗
U.S. Food and Drug Administration · Official source · Source checked July 29, 2026
2
Certain bulk drug substances for use in compounding that may present significant safety risks ↗
U.S. Food and Drug Administration · Official source · Source checked July 29, 2026
3
BPC 157 for Acute Hamstring Muscle Strain Repair · record history version 1 · last update posted 2026-02-27 ↗
ClinicalTrials.gov · Official source · Source checked July 22, 2026